Evidence map›Paper›PMID 27905004›Full record

ArticleAAPS PharmSciTech2017

Ocular Disposition of ∆

Nagendra S Punyamurthula, Goutham R Adelli, Waseem Gul, Michael A Repka, Mahmoud A ElSohly, Soumyajit Majumdar

Open access · bronzeAbstract read
In one paragraph

Article in AAPS PharmSciTech, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Nanocarriers for Cannabinoid Delivery: Enhancing Therapeutic Potential.Recent advances in drug delivery and formulation · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. ΔTranslational vision science & technology · 2019
    Article
  14. Role of Endocannabinoids in Glaucoma: A Review.Journal of current glaucoma practice
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nagendra S PunyamurthulaDepartment of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA.
Goutham R AdelliDepartment of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA.
Waseem GulElSohly Laboratories Inc., 5-Industrial Park Drive, Oxford, Mississippi, 38655, USA.
Michael A RepkaDepartment of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA.
Mahmoud A ElSohlyDepartment of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA.
Soumyajit MajumdarDepartment of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA. majumso@olemiss.edu.
University of Mississippi · USElSohly Laboratories (United States) · US

Funding

Center of Research Excellence in Natural Products Neuroscience (CORE-NPN)P20GM104932 · NIGMS · UNIVERSITY OF MISSISSIPPI · PI MAJUMDAR, SOUMYAJIT · 2012 to 2016
$10.0M
NIGMS NIH HHS P20 GM104932
6 · The paper itself

Abstract

The purposes of this project are to enhance the trans-membrane penetration of Δ

Indexed as

Administration, OphthalmicAdministration, TopicalAnalgesics, Non-NarcoticAnimalsCorneaDronabinolDrug CompoundingDrug Delivery SystemsMaleNanoparticlesParticle SizeRabbitsAnalgesics, Non-NarcoticDronabinollipid-based drug deliveryocular drug deliveryocular filmssolid lipid nanoparticlestetrahydrocannabinol

Identifiers

PMID27905004
PMCPMC5629008
OpenAlexW2559130626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.